Improvement of blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medicine for antidiabetic therapy is 10 mg of dapagliflozin and 100 mg of sitagliptin; the dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg.
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. If the dose of metformin hydrochloride needs adjustment, adjust it gradually.
Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily.
Patients taking this medicine as 5/50/500 mg, 5/50/750 mg, or 5/50/1000 mg extended-release tablets should take 2 tablets once daily.
If adequate glycemic control cannot be achieved with combination therapy of metformin hydrochloride and sitagliptin, the starting dose of this medicine should be dapagliflozin 10 mg, sitagliptin 100 mg, and the current dose of metformin hydrochloride, or a therapeutically equivalent dose.
For patients switching from combination therapy with dapagliflozin, sitagliptin, and metformin hydrochloride to this medicine, the dose of this medicine should be the existing dose of each component.
No dose adjustment is required in patients with mild renal impairment.
If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher and below 60 mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride, one of its components, provided the patient tolerates it well and has no other symptoms that may increase the risk of lactic acidosis.
The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg.
If the estimated glomerular filtration rate (eGFR) decreases to below 45 mL/min/1.73m2, treatment with this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months.
Improvement of blood glucose control in type 2 diabetes
View approved original textHide original text
This medication is used for patients with type 2 diabetes to improve blood sugar control while assisting meal therapy and exercise therapy when taken with dapagliflozin, sitagliptin, and metformin.
How to take
Adult dose
The recommended dose of this medicine for antidiabetic therapy is 10 mg of dapagliflozin and 100 mg of sitagliptin; the dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg.
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. If the dose of metformin hydrochloride needs adjustment, adjust it gradually.
Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily.
Patients taking this medicine as 5/50/500 mg, 5/50/750 mg, or 5/50/1000 mg extended-release tablets should take 2 tablets once daily.
If adequate glycemic control cannot be achieved with combination therapy of metformin hydrochloride and sitagliptin, the starting dose of this medicine should be dapagliflozin 10 mg, sitagliptin 100 mg, and the current dose of metformin hydrochloride, or a therapeutically equivalent dose.
For patients switching from combination therapy with dapagliflozin, sitagliptin, and metformin hydrochloride to this medicine, the dose of this medicine should be the existing dose of each component.
No dose adjustment is required in patients with mild renal impairment.
If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher and below 60 mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride, one of its components, provided the patient tolerates it well and has no other symptoms that may increase the risk of lactic acidosis.
The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg.
If the estimated glomerular filtration rate (eGFR) decreases to below 45 mL/min/1.73m2, treatment with this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months.
Precautions
This medication contains three components: sitagliptin, dapagliflozin, and metformin.
First, the sitagliptin component can cause severe allergic reactions, so if you experience skin rash, difficulty breathing, or swelling of the face or lips, you must stop taking this medication immediately.
Additionally, acute pancreatitis may occur, which means inflammation of the pancreas, so if sudden abdominal pain or vomiting occurs, you should visit the hospital quickly.
Next, the metformin component can rarely cause a serious metabolic disorder called lactic acidosis. This symptom occurs due to the accumulation of lactic acid in the body, and symptoms such as weakness, muscle pain, difficulty breathing, and abdominal pain may appear, so if these symptoms occur, you should consult a healthcare professional immediately.
Moreover, it is safer not to use this medication for patients with decreased kidney function, severe infections, dehydration, heart failure, or unstable conditions such as acute myocardial infarction.
Patients who are scheduled to receive iodine contrast agents for radiological examinations should discontinue this medication for a certain period before and after the examination and should resume taking it only after confirming normal kidney function.
Patients with decreased blood volume or low blood pressure, the elderly, or patients taking diuretics should carefully monitor their condition as they may be at risk for decreased blood pressure or worsening kidney function while using this medication.
Infections of the genital area and urinary tract may occur during the use of this medication, so if related symptoms appear, immediate treatment should be sought.
Additionally, hypoglycemic symptoms may occur, so especially when combined with other diabetes medications such as insulin or sulfonylureas, blood sugar changes should be monitored closely.
It is advisable not to use this medication during pregnancy, when there are issues with placental function, or in patients with significantly reduced liver function.
Finally, this medication can rarely cause skin rash, urticaria, severe joint pain, and blistering skin diseases, so if abnormal symptoms occur, you should consult a doctor immediately.
During the use of this medication, it is essential to regularly check health status through blood tests and kidney function tests.
Side effects
Severe hypersensitivity reactions
anaphylaxis
angioedema
Stevens-Johnson syndrome
exfoliative skin disease
acute pancreatitis
hemorrhagic pancreatitis
necrotizing pancreatitis
lactic acidosis
hypoglycemia
Show 142 moreCollapse
genital infection
vulvitis
balanitis
fungal infection
perineal necrosis
fluid volume reduction
dehydration
hypovolemia
hypotension
diabetic ketoacidosis
urinary tract infection
cystitis
E. coli urinary tract infection
genitourinary infections
pyelonephritis
trigonal cystitis
urethritis
kidney infection
prostatitis
dizziness
constipation
dry mouth
low back pain
dysuria
polyuria
nocturia
interstitial nephritis
vulvar pruritus
genital pruritus
increased hematocrit
decreased serum creatinine clearance
dyslipidemia
elevated serum creatinine
elevated blood urea
weight loss
rash
generalized rash
pruritic rash
maculopapular rash
papular rash
pustular rash
vesicular rash
erythematous rash
acute renal failure
upper respiratory tract infection
nasopharyngitis
constipation
vomiting
headache
severe arthralgia
vesicular pemphigoid
myalgia
limb pain
back pain
interstitial lung disease
pruritus
thrombocytopenia
rhabdomyolysis
gastroesophageal reflux disease
epigastric pain
diverticulosis
intestinal perforation
chronic pancreatitis
hyperglycemia
paresthesia
cerebral infarction
nerve compression
sinusitis
diverticulitis
pelvic inflammatory disease
pneumonia
pulmonary tuberculosis
asthenia
pain
ligament sprain
road traffic accident
drug overdose
ankle fracture
hand fracture
iliac fracture
meniscus injury
thoracic vertebra fracture
tibial fracture
keratitis
chronic obstructive pulmonary disease
hemoptysis
cerebral hemorrhage
peripheral artery occlusion
angina
myocardial infarction
bile duct stones
cholangitis
alcoholic liver cirrhosis
depression
suicide attempt
gastric adenocarcinoma
anaphylactic reaction
acute pyelonephritis
chest pain
dyspepsia
nausea
diarrhea
vomiting
urinary retention
elevated alanine aminotransferase
elevated aspartate aminotransferase
decreased appetite
next-day syndrome
headache
nasopharyngitis
asthenia
hunger
vaginal discharge
pruritus
urticaria
sweating
arthralgia
musculoskeletal pain
limb pain
muscle weakness
myalgia
osteoarthritis
ligament sprain
diabetic retinopathy
cough
dyspnea
orthostatic hypotension
palpitations
insomnia
fatty liver
gallbladder polyp
tinnitus
taste disturbance
nausea
vomiting
diarrhea
abdominal pain
appetite loss
erythema
pruritus
urticaria
rash
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly closed container to protect it from air and light, at room temperature between 1 and 30 degrees Celsius.
Storing it this way helps maintain the medication's effectiveness over time.
Appearance and packaging
Appearance
Orange oval extended release film-coated tablet
Package unit
30 tablets/bottle
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.